December 23, the sub-CDE and sub-CMDE, NMPA, in Great Bay Area opened officially in Futian District, Shenzhen.The NMPA and CDE leaders, Guangdong Provincial Drug Administration Director Jiang Xiaodong, Guangdong Provincial Drug Administration Deputy Director Yan Zhen attended the opening ceremony. 

Last month, the state administration of market regulation and so on eight departments jointly issued by the Hong Kong and Macao to the large bay medicine medical device regulatory scheme for innovation and development "(hereinafter referred to as" the plan "), which mainly referred to the Hong Kong and Macao to the big bay area to further deepen the reform of the drug review of medical equipment examination and approval system, set up a national pharmaceutical medical equipment technology branch, Hong Kong and Macao to promote large bay biological medicine industry innovation cluster development.

According to the Plan, the Greater Bay Area Sub-Center will serve as the dispatched agency of the Drug and Medical Device Evaluation Center of the State Food and Drug Administration, mainly responsible for assisting the Drug and Medical Device Evaluation Center of the State Food and Drug Administration to carry out pre-event communication and guidance and related inspections, and to establish a convenient mechanism for evaluation and approval.